TrialAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Modified titration of donanemab reduces ARIA risk and maintains amyloid reduction.

Hong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.